Ghassan El-Haddad, MD

Senior Member Interventional Radiology, Medical Director Radionuclide Therapy Program
Moffitt Cancer Center and Research Institute, United States

Presentation(s):

• Splenic Radioembolization in Patients with Extreme Splenomegaly

  Sunday, March 30, 2025
  3:54 PM – 4:03 PM CT

• Interventional Oncology 1

  Sunday, March 30, 2025
  3:00 PM – 4:30 PM CT

• Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET)

  Sunday, March 30, 2025
  3:54 PM – 4:03 PM CT

• Embolics and Delivery Systems (Radioactive, drug-eluting, bland, liquid, gel, conformable, plugs, coils) (separate registration required)

  Monday, March 31, 2025
  8:30 AM – 10:00 AM CT

• Associations between patterns of neuroendocrine liver metastatic burden and outcomes after liver-directed therapy, systemic chemotherapy and systemic radiotherapy.

  Tuesday, April 1, 2025
  3:36 PM – 3:45 PM CT